SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Senate Committee OK’s extra $40m to FDA but refuses Obama’s $146m plan

The Senate Committee on Appropriations has approved $2.6bn in funding to the US FDA for FY2016.

The Senate Committee on Appropriations approved a modest increase to FDA funding

FDA offers draft guidance on quality metrics used to assess drug manufacturing

New FDA draft guidance offers drug and API manufacturers a peek into the measurements or metrics that will be used to evaluate the quality of the facilities and the processes that they use to make drugs and biologics.

Hikma buys B-I generics subsidiary, strengthens position in US market

Hikma says its $2.65bn acquisition of Roxane Laboratories will make it the sixth largest firm in the US generics space.

US FDA finalises analytical procedures and methods validation guidance

Pharma firms may need to carry-out an analytical method comparability study as part of the life cycle management of a drug, according to final US FDA guidelines.

PEOPLE ON THE MOVE

Senior changes at Sanofi-Merck JV, Novo Nordisk, ABPI, and MedImmune

New faces in pharma in our weekly column.

Update

Teva to buy Allergan's generics biz for $40.5bn

Teva has struck a deal to buy Allergan’s generics business a week after its persistent attempts to acquire Mylan fell through.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...